Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | CARA |
---|---|---|
09:32 ET | 48708 | 0.44 |
09:34 ET | 17271 | 0.4501 |
09:36 ET | 40560 | 0.453519 |
09:38 ET | 700 | 0.44 |
09:39 ET | 100 | 0.4535 |
09:41 ET | 28901 | 0.44 |
09:43 ET | 12596 | 0.44 |
09:45 ET | 13576 | 0.44 |
09:48 ET | 5674 | 0.441 |
09:50 ET | 5600 | 0.44 |
09:52 ET | 34936 | 0.425 |
09:54 ET | 3672 | 0.421 |
09:56 ET | 226236 | 0.43 |
09:57 ET | 100773 | 0.4299 |
09:59 ET | 1022 | 0.421 |
10:01 ET | 32895 | 0.4297 |
10:03 ET | 3251 | 0.425 |
10:06 ET | 3856 | 0.4294 |
10:08 ET | 35478 | 0.414156 |
10:10 ET | 2921 | 0.4188 |
10:12 ET | 11333 | 0.4189 |
10:14 ET | 1296 | 0.4188 |
10:15 ET | 3782 | 0.4236 |
10:17 ET | 100 | 0.4245 |
10:19 ET | 4888 | 0.4211 |
10:21 ET | 3189 | 0.4274 |
10:24 ET | 3040 | 0.4273 |
10:26 ET | 2751 | 0.4273 |
10:28 ET | 100 | 0.4273 |
10:30 ET | 43460 | 0.4299 |
10:32 ET | 700 | 0.42865 |
10:33 ET | 200 | 0.42865 |
10:35 ET | 1235 | 0.429512 |
10:37 ET | 2750 | 0.4274 |
10:39 ET | 5800 | 0.4298 |
10:42 ET | 38770 | 0.4315 |
10:44 ET | 1031 | 0.433 |
10:46 ET | 3300 | 0.43 |
10:48 ET | 230 | 0.43 |
10:50 ET | 62009 | 0.4255 |
10:51 ET | 8308 | 0.427975 |
10:53 ET | 4368 | 0.43 |
10:55 ET | 200 | 0.43 |
10:57 ET | 752 | 0.4251 |
11:00 ET | 180 | 0.4251 |
11:02 ET | 480 | 0.425 |
11:04 ET | 4698 | 0.4251 |
11:06 ET | 5200 | 0.4263 |
11:08 ET | 1700 | 0.43 |
11:09 ET | 1150 | 0.432027 |
11:11 ET | 4390 | 0.430101 |
11:13 ET | 5721 | 0.43 |
11:18 ET | 340 | 0.43 |
11:20 ET | 610 | 0.43 |
11:22 ET | 12332 | 0.435 |
11:24 ET | 1520 | 0.435 |
11:26 ET | 8636 | 0.4351 |
11:27 ET | 1320 | 0.435 |
11:29 ET | 380 | 0.4358 |
11:31 ET | 1344 | 0.4358 |
11:33 ET | 2291 | 0.4351 |
11:36 ET | 9700 | 0.435 |
11:38 ET | 390 | 0.4351 |
11:40 ET | 5600 | 0.4351 |
11:42 ET | 798 | 0.4351 |
11:44 ET | 401 | 0.4351 |
11:45 ET | 200 | 0.435 |
11:47 ET | 400 | 0.435 |
11:49 ET | 100 | 0.435 |
11:51 ET | 925 | 0.435 |
11:54 ET | 692 | 0.4351 |
11:56 ET | 822 | 0.43505 |
11:58 ET | 3909 | 0.4351 |
12:00 ET | 2330 | 0.435 |
12:02 ET | 100 | 0.435 |
12:03 ET | 100 | 0.435 |
12:05 ET | 550 | 0.435 |
12:07 ET | 1210 | 0.435 |
12:09 ET | 537 | 0.435 |
12:12 ET | 725 | 0.43505 |
12:14 ET | 1010 | 0.435 |
12:18 ET | 100 | 0.4351 |
12:20 ET | 580 | 0.4351 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Cara Therapeutics Inc | 37.2M | -0.2x | --- |
ImmuCell Corp | 33.4M | -8.3x | --- |
Aadi Bioscience Inc | 41.7M | -0.7x | --- |
Aligos Therapeutics Inc | 39.8M | -0.3x | --- |
Turnstone Biologics Corp | 65.7M | -0.8x | --- |
SQZ Biotechnologies Co | 884.7K | 0.0x | --- |
Cara Therapeutics, Inc. is a development-stage biopharmaceutical company. The Company is focused on treatment paradigm to improve the lives of patients suffering from chronic pruritus. It is developing an oral formulation of difelikefalin, a selective, predominantly peripherally acting, non-scheduled Kappa opioid receptor agonist, for the treatment of chronic neuropathic pruritus associated with Notalgia Paresthetica (NP), a common, underdiagnosed neuropathy affecting the upper back. It is conducting Phase II/III Clinical Program in NP. The program is comprised of two studies - KOURAGE 1 and KOURAGE 2, which are double-blind, placebo-controlled, eight-week studies with patients allowed to roll-over into open-label 52-week extensions. It has developed an IV formulation of difelikefalin, for the treatment of moderate-to-severe pruritus associated with advanced chronic kidney disease in adults undergoing hemodialysis. The IV formulation is out-licensed worldwide.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $37.2M |
---|---|
Revenue (TTM) | $16.9M |
Shares Outstanding | 54.7M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.78 |
EPS | $-2.26 |
Book Value | $1.05 |
P/E Ratio | -0.2x |
Price/Sales (TTM) | 2.2 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -729.19% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.